New study aims to streamline uveitis diagnosis and cut costs
NCT ID NCT01162070
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at 905 people with uveitis, an eye inflammation, to see if a standardized step-by-step diagnostic plan works as well as letting doctors choose any tests they want. The goal was to find the cause of the uveitis more efficiently and at a lower cost. Researchers compared the percentage of patients diagnosed within six months using each strategy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more efficient and cost-effective way to diagnose the causes of uveitis, potentially improving patient care.
- What could go wrong
- This is an observational study comparing diagnostic strategies, not testing a new treatment. The results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Médecine Interne, Hospices Civils de Lyon (HCL)-Hôpital de la Croix Rousse
Lyon, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test allow uveitis patients to safely take less medication?
- New DNA test could revolutionize diagnosis of eye infections
- New drug aims to tame eye inflammation in uveitis patients
- New hope for kids with eye inflammation: baricitinib trial shows promise
- New study aims to uncover uveitis patterns in kids
- New study aims to unlock secrets of rare childhood eye disease